Compositions and use of benzamides and nicotinamides as anti-inf

Details Compositions and use of benzamides and nicotinamides as anti-inf Compositions and use of benzamides and nicotinamides as anti-inf

1997-02-27

2000-02-22

MacMillan, Keith D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514886, 514887, A61K 31165

Patent

active

060281111

ABSTRACT:
The use of benzamide and nicotinamide analogs, in particular N-substituted benzamides and nicotinamides, other than benzamides with N-pyridinyl substitutions, as anti-inflammatory agents.

REFERENCES:
patent: 4146637 (1979-03-01), Metz et al.
patent: 4263322 (1981-04-01), van't Riet et al.
patent: 4394389 (1983-07-01), van't Riet et al.
patent: 4448730 (1984-05-01), van't Riet et al.
patent: 4623659 (1986-11-01), van't Riet et al.
patent: 4942253 (1990-07-01), van't Riet et al.
patent: 5183828 (1993-02-01), van't Riet et al.
patent: 5350770 (1994-09-01), Elford et al.
patent: 5366996 (1994-11-01), Elford et al.
Chemical Abstracts AN 1995:886480, Lang et al, "New Antiinflammatory compounds that inhibit TNF production", J. Pharmacol. Exp. Ther. (1995), 275(1), 171-6, Jan. 1995.
Chemical Abstracts AN 1993:670811, Nagar, "A process for the preparation of novel pharmacological active N-substituted benzamide-2-carboxylic acid and their metal complexes", IN 170840 A, May 30, 1992.
Chemical Abstracts AN 1972:14045, "Synthesis and antiinflammatory activity of fluorinated benzamides", Sch. Pharm. Sci. (1971), 60(11), 1723-5, Jan. 1971.
Chemical Abstracts AN 1995:998575, Ali et al., Jan. 1995.
Chemical Abstracts AN 1978:36738, Topart et al., Jan. 1976.
Medline Abstract No. 91244895, Uetrecht et al., Jan. 1991.
Berk et al., Arch. Dermatol., 122:670-74 (1986).
Pozzilli et al., Diabetes Care, 17(8):897-900 (1994).
Jonas et al., Inflamm. Res. 45:330-34 (1996).
Garcia de Jalon et al., Arzneim.-Forsch./Drug Res. 29(II), Nr. 11:1704-07 (1979).
Nagar et al., J. Inorg. Biochem., 42:9-16 (1991).
Hirohashi et al., Arzneim.-Forsch. Drug Res. 43(I), Nr. 5:569-77 (1993).
Hall et al., Acta Pharm. Nord., 2(6):387-99 (1990).
Dorsey et al., J. Pharm. Sci., 60:1723-25 (1971).
Vernhet et al., J. Pharmacol. Exp. Ther. 283:358-65 (1997).
Naik et al., Ind. J. Exp. Biol. 17:1353-56 (1979).
Lang et al., J. Pharmacol. Exp. Ther. 275:171-76 (1995).
Marak, Jr. et al., Ophthalmic Res. 22:111-16 (1990).
Naik et al., Ind. J. Exp. Biol., 16:1169-74 (1978).
Pedrazzoli et al., Boll. Chim. Farm., 115:125-35 (1976).
Hanoeq et al., J. Pharm. Belg., 28(6):649-62 (1973) + translation.
Topart et al., Pharm. Acta Melv. 51(11):314-25 (1976) + translation.
Amiri et al., "Apoptosis in HL-60 cells as aModel . . . " unpub., p. 21 + 6 Figs., submitted to Acta Oncologica (1997).
Baeuerle et al., Cell 87: 13-20 (1996).
Beg et al., Science 274:782-84 (1996).
Bauhayat et al., J. Med. Chem. 28:555-59 (1985).
Harrington et al., Drugs 25: 451-94 (1983).
Horsman, Acta Oncologica 34:571-87 (1995).
King et al., Drugs of the Future 14 (g) : 875-89 (1989).
Moffett et al., J. Med. Chem. 14:963-68 (1971).
Moragues et al., Quim. Ind. (Madrid) 17:104-05 (1971).
Olsson et al., Biochem. Pharmacol. 45:1191-1200 (1993).
Olsson et al.a, Carcinogenesis 16:1029-35 (1995).
Olsson et al., Brit. J. Cancer 74:368-73 (1996).
Pero et al., Biochemie 77:385-93 (1995).
Pero et al., "Multiple Mechanisms of action of the benzamides and nicotinamides . . . ," unpub., p. 21 + 6 sheets of figs., submitted to Cancer Prevent. (1997.
F. Piriou et al., Experimentia 41:1409-10 (1985).
Robert-Piessard et al., Eur. J. Med. Chem. 25:9-19 (1990).
Stanley et al., ed., The Benzamides: Pharmacology, Neurobiology, and Clinical Aspects, Advances in Biochemical Psychopharmacology, vol. 35 (New York: Raven Press, 1982), pp. 1-60, 195-203.
Thompson, Science 267:1456-62 (1995).
VanAntwerp et al., Science 274:787-89 (1996).
Wang et al., Science 274:784-87 (1996).

Affiliated with

Also associated with

Rating

Compositions and use of benzamides and nicotinamides as anti-inf does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and use of benzamides and nicotinamides as anti-inf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and use of benzamides and nicotinamides as anti-inf will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-520969